Dr. Reddy's Laboratories Ltd - Company Profile
Powered by 
All the data and insights you need on Dr. Reddy's Laboratories Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Dr. Reddy's Laboratories Ltd Strategy Report
- Understand Dr. Reddy's Laboratories Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Dr. Reddy's Laboratories Catalyst Calendar
Proactively evaluate Dr. Reddy's Laboratories Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Dr. Reddy's Laboratories Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 16 Apr 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 15 Apr 2020 | Phase II Trial Completion | Dr. Reddy's Laboratories Ltd; Madras Diabetes Research Foundation | DRREDDY | Celevida | Metabolic Disorders | Obesity; Type 2 Diabetes | Clinical Trial Registry |
| 24 Feb 2020 | Phase II Trial Completion | Dr. Reddy's Laboratories Ltd; Postgraduate Institute of Medical Education and Research | DRREDDY | mirabegron | Genito Urinary System And Sex Hormones | Renal Stones/Calculi; Unspecified Genito Urinary Disorders | Clinical Trial Registry |
| 15 Jan 2020 | Phase II Trial Initiation | Dr. Reddy's Laboratories Ltd | DRREDDY | AUR-101 | Immunology | Plaque Psoriasis (Psoriasis Vulgaris); Psoriasis | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer